InvestorsHub Logo
Followers 33
Posts 1603
Boards Moderated 0
Alias Born 10/06/2015

Re: 3X Charm post# 168881

Wednesday, 06/02/2021 9:42:24 PM

Wednesday, June 02, 2021 9:42:24 PM

Post# of 231511
You'll notice that in using the phrase "off-label", I put the phrase in quotes and added a "so-to-speak" qualifier. Since there is "no label" I agree it cannot be truly "off-label."

The assumption being - the key use of leronlimab in the Philippines is expected to be a treatment for Covid-19.

I believe, as stated, this is just a starting point. The Philippines is already a destination for medical tourism, so it's not a quantum leap to assume their doctors/hospitals/tourism ministry will fail to grasp the potential of leronlimab to enlarge upon this source of income for their country.

In fact I hope they do. :)

FWIW - Currently the Philippines is ranked 8th in the world in Medical Tourism and is striving to climb in these ratings.

"SunStar CEBU reports that the Philippines is seeing 80,000 to 250,000 medical tourists annually. Patients come from Sri Lanka, East Asia, the Gulf States, Europe, North and South America, the Pacific Islands, Australia and the Pacific Islands. Filipino workers and expatriates also travel back home to the Philippines to have their medical procedures[1]."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News